Search research articles
Contact Us
Filters
Showing results (431-440 of 464) with videos related to
Page
of 47
Sort By:
The American Journal of Pathology
|
August 30, 2005
Bb2Bb3 regulation of murine Lyme arthritis is distinct from Ncf1 and independent of the phagocyte nicotinamide adenine dinucleotide phosphate oxidase
Hillary Crandall, Ying Ma, Diane M Dunn, et al.
Cell Death & Disease
|
June 13, 2014
Loss of function of the ALS protein SigR1 leads to ER pathology associated with defective autophagy and lipid raft disturbances
J T Vollrath, A Sechi, A Dreser, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 2, 2012
Endothelial cells and fibroblasts amplify the arthritogenic type I IFN response in murine Lyme disease and are major sources of chemokines in Borrelia burgdorferi-infected joint tissue
Robert B Lochhead, F Lynn Sonderegger, Ying Ma, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 21, 2025
The transcription factor BCL11B drives NK cell cytotoxicity and antitumor activity
Akhilesh Kumar, Bin Zhang, Andrew Baldys, et al.
Infection and Immunity
|
June 3, 2009
Interval-specific congenic lines reveal quantitative trait Loci with penetrant lyme arthritis phenotypes on chromosomes 5, 11, and 12
Ying Ma, Jennifer C Miller, Hillary Crandall, et al.
Surgery
|
September 4, 2012
Radiographic assessment of splenic injury without contrast: is contrast truly needed?
Douglas R Murken, Joshua J Weis, Geoffrey C Hill, et al.
BMC Cancer
|
August 16, 2019
Outcomes and outcome measures used in evaluation of communication training in oncology - a systematic literature review, an expert workshop, and recommendations for future research
F Fischer, S Helmer, A Rogge, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
Immunoregulatory functions of complement: structural and functional studies of complement receptor type 1 (CR1; CD35) and type 2 (CR2; CD21)
D T Fearon, L B Klickstein, W W Wong, et al.
Investigational New Drugs
|
March 19, 2013
A phase I/II study of decitabine in combination with panitumumab in patients with wild-type (wt) KRAS metastatic colorectal cancer
I Garrido-Laguna, K A McGregor, M Wade, et al.
Clinical Genetics
|
May 8, 2010
The p.P56S mutation in the VAPB gene is not due to a single founder: the first European case
A D Funke, M Esser, A Krüttgen, et al.
Page
of 47
Search research articles
Search
Showing results (431-440 of 464) with videos related to
Sort By:
Page
of 47
The American Journal of Pathology
|
August 30, 2005
Bb2Bb3 regulation of murine Lyme arthritis is distinct from Ncf1 and independent of the phagocyte nicotinamide adenine dinucleotide phosphate oxidase
Hillary Crandall, Ying Ma, Diane M Dunn, et al.
Cell Death & Disease
|
June 13, 2014
Loss of function of the ALS protein SigR1 leads to ER pathology associated with defective autophagy and lipid raft disturbances
J T Vollrath, A Sechi, A Dreser, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 2, 2012
Endothelial cells and fibroblasts amplify the arthritogenic type I IFN response in murine Lyme disease and are major sources of chemokines in Borrelia burgdorferi-infected joint tissue
Robert B Lochhead, F Lynn Sonderegger, Ying Ma, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 21, 2025
The transcription factor BCL11B drives NK cell cytotoxicity and antitumor activity
Akhilesh Kumar, Bin Zhang, Andrew Baldys, et al.
Infection and Immunity
|
June 3, 2009
Interval-specific congenic lines reveal quantitative trait Loci with penetrant lyme arthritis phenotypes on chromosomes 5, 11, and 12
Ying Ma, Jennifer C Miller, Hillary Crandall, et al.
Surgery
|
September 4, 2012
Radiographic assessment of splenic injury without contrast: is contrast truly needed?
Douglas R Murken, Joshua J Weis, Geoffrey C Hill, et al.
BMC Cancer
|
August 16, 2019
Outcomes and outcome measures used in evaluation of communication training in oncology - a systematic literature review, an expert workshop, and recommendations for future research
F Fischer, S Helmer, A Rogge, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
Immunoregulatory functions of complement: structural and functional studies of complement receptor type 1 (CR1; CD35) and type 2 (CR2; CD21)
D T Fearon, L B Klickstein, W W Wong, et al.
Investigational New Drugs
|
March 19, 2013
A phase I/II study of decitabine in combination with panitumumab in patients with wild-type (wt) KRAS metastatic colorectal cancer
I Garrido-Laguna, K A McGregor, M Wade, et al.
Clinical Genetics
|
May 8, 2010
The p.P56S mutation in the VAPB gene is not due to a single founder: the first European case
A D Funke, M Esser, A Krüttgen, et al.
Page
of 47